Haolong Qi

463 total citations
16 papers, 321 citations indexed

About

Haolong Qi is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Haolong Qi has authored 16 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in Haolong Qi's work include Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Haolong Qi is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Haolong Qi collaborates with scholars based in China, Hong Kong and United States. Haolong Qi's co-authors include Yusha Xiao, Quanyan Liu, Yufeng Yuan, Tao Guo, Lei Chang, Zhisu Liu, Cuicui Li, Dong Xu, Yuan Li and Xiaoqing Cai and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Oncology and International Journal of Pharmaceutics.

In The Last Decade

Haolong Qi

14 papers receiving 320 citations

Peers

Haolong Qi
Haolong Qi
Citations per year, relative to Haolong Qi Haolong Qi (= 1×) peers Haoming Xia

Countries citing papers authored by Haolong Qi

Since Specialization
Citations

This map shows the geographic impact of Haolong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolong Qi more than expected).

Fields of papers citing papers by Haolong Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haolong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolong Qi. The network helps show where Haolong Qi may publish in the future.

Co-authorship network of co-authors of Haolong Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Haolong Qi. A scholar is included among the top collaborators of Haolong Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolong Qi. Haolong Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
3.
Qi, Haolong, et al.. (2025). Preparation of pH-enzyme dual-responsive gel microspheres and their treatment of ulcerative colitis. International Journal of Biological Macromolecules. 306(Pt 2). 141567–141567. 1 indexed citations
4.
Qi, Haolong, Bin Wang, & Lei Zhu. (2024). Independent associations of serum calcium with or without albumin adjustment and serum phosphorus with nonalcoholic fatty liver disease: results from NHANES 1999-2018. Frontiers in Endocrinology. 15. 1323990–1323990. 3 indexed citations
5.
Li, Yuan, et al.. (2024). Research progress of organic photothermal agents delivery and synergistic therapy systems. Colloids and Surfaces B Biointerfaces. 234. 113743–113743. 30 indexed citations
6.
Qi, Haolong, et al.. (2024). Nanoparticle-mediated immunogenic cell death for cancer immunotherapy. International Journal of Pharmaceutics. 656. 124045–124045. 9 indexed citations
7.
Qi, Haolong, Wende Li, Jie Zhang, et al.. (2020). Glioma-associated oncogene homolog 1 stimulates FOXP3 to promote non-small cell lung cancer stemness.. PubMed. 12(5). 1839–1850. 4 indexed citations
8.
Hao, Jia, Haolong Qi, Zhongqin Gong, et al.. (2019). The expression of FOXP3 and its role in human cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(1). 170–178. 51 indexed citations
9.
Hao, Jia, et al.. (2019). FOXP3Δ3, the major isoform of FOXP3, promotes proliferation, migration, and invasion in non-small cell lung cancer. Annals of Oncology. 30. ii5–ii6. 2 indexed citations
10.
Qi, Haolong, Shanshan Wang, Shucai Yang, et al.. (2019). EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 11. 3862470268–3862470268. 16 indexed citations
11.
Chang, Lei, Haolong Qi, Yusha Xiao, et al.. (2016). Integrated analysis of noncoding RNAs and mRNAs reveals their potential roles in the biological activities of the growth hormone receptor. Growth Hormone & IGF Research. 29. 11–20. 11 indexed citations
12.
Chang, Lei, Yufeng Yuan, Cuicui Li, et al.. (2016). Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Letters. 383(2). 183–194. 129 indexed citations
13.
Qi, Haolong. (2015). Peri-operative use of sorafenib in liver transplantation: A time-to-event meta-analysis. World Journal of Gastroenterology. 21(5). 1636–1636. 5 indexed citations
14.
Qi, Haolong, Changsheng Li, Yusha Xiao, et al.. (2015). The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma. Tumor Biology. 37(1). 1079–1089. 33 indexed citations
15.
Li, Ting, Tao Guo, Haolong Qi, et al.. (2015). The Plasma S-adenosylmethionine Level is Associated With the Severity of Hepatitis B-Related Liver Disease. Medicine. 94(4). e489–e489. 9 indexed citations
16.
Zhu, Siying, Ting Li, Weijun Liu, et al.. (2014). Glucocorticoid-induced S-Adenosylmethionine Enhances the Interferon Signaling Pathway by Restoring STAT1 Protein Methylation in Hepatitis B Virus-infected Cells. Journal of Biological Chemistry. 289(47). 32639–32655. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026